SOLO-1 phase III trial demonstrates Lynparza maintenance therapy cut the risk of disease progression or death by 70% in advanced BRCA-mutated ovarian cancer

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

If you listen to GRAIL executives discuss the results of the long-awaited trial of the company’s multicancer detection test, you might be led to conclude that the company’s pivotal NHS-Galleri study had an overwhelmingly positive result.

March 06, 2026

By Jacquelyn Cobb and Sara Willa Ernst

Cancer Policy

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

Mount Sinai hospital has formed a committee to investigate the ties between Jeffrey Epstein and Eva Dubin a leading doctor at the hospital and founder of the Dubin Breast Center at the Tisch Cancer Institute whose name is featured prominently in the Epstein files.

March 06, 2026

By Claire Marie Porter and Sara Willa Ernst

Cancer Policy

House member introduces bill to increase funding for MCD testing of firefighters

Rep. Josh Gottheimer (D-NJ) introduced the FIRE Cancer Act on Feb. 27. The piece of legislation seeks to increase grant dollars available to local fire departments, specifically earmarked for cancer prevention, “including providing multi-cancer early detection testing or other forms of preventative tests.”

March 06, 2026

By Sara Willa Ernst

In Brief

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

W. Kimryn Rathmell, CEO of the James Cancer Hospital and Solove Research Institute, has also been named director of The Ohio State University Comprehensive Cancer Center in place of former Director Raphael E. Pollock, who has stepped down from the position he had held since November 2017 to become OSUCCC director emeritus.

March 06, 2026

In Brief

Bob Gray steps down as ECOG-ACRIN group statistician

Bob Gray has retired from his role as Group Statistician, Therapeutics, for the ECOG-ACRIN Cancer Research Group, as of Feb. 28.

March 06, 2026

In Brief

Eric Gardner, Betty Kim, Rodrigo Romero, and Hojong Yoon appointed members of MD Anderson’s Allison Institute

Eric Gardner, Betty Kim, Rodrigo Romero, and Hojong Yoon were appointed members of the James P. Allison Institute at The University of Texas MD Anderson Cancer Center.

March 06, 2026

SOLO-1 phase III trial demonstrates Lynparza maintenance therapy cut the risk of disease progression or death by 70% in advanced BRCA-mutated ovarian cancer

YOU MAY BE INTERESTED IN

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

House member introduces bill to increase funding for MCD testing of firefighters

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Bob Gray steps down as ECOG-ACRIN group statistician

Eric Gardner, Betty Kim, Rodrigo Romero, and Hojong Yoon appointed members of MD Anderson’s Allison Institute

Renew today!

Subscriber content

Never miss an issue!

Login

SOLO-1 phase III trial demonstrates Lynparza maintenance therapy cut the risk of disease progression or death by 70% in advanced BRCA-mutated ovarian cancer

YOU MAY BE INTERESTED IN

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal studyWhere GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

House member introduces bill to increase funding for MCD testing of firefighters

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Bob Gray steps down as ECOG-ACRIN group statistician

Eric Gardner, Betty Kim, Rodrigo Romero, and Hojong Yoon appointed members of MD Anderson’s Allison Institute

Never miss an issue!

Login

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis